Market revenue in 2023 | USD 1,538.9 million |
Market revenue in 2030 | USD 2,791.5 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Next generation sequencing |
Fastest growing segment | Next Generation Sequencing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Next Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays |
Key market players worldwide | Johnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 36.95% in 2023. Horizon Databook has segmented the Canada next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of cancer care centers such as Cancer Care Ontario, Prostate Cancer Canada, and Atlantic Cancer Research Institute that are involved in development of companion diagnostics and personalized medicine are anticipated to impact regional growth through to 2024.
According to data published by the Canadian Cancer Statistics, it has been estimated that burden of cancer on Canadian population in 2014 was 191,300 and the mortality was about 76,600.
Research carried out by the market entities in order to curb these rising rates of cancer incidence is estimated to provide this region with a number of lucrative avenues for growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada next generation cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account